Potential biomarker in serum for predicting susceptibility to type 2 diabetes mellitus: Free fatty acid 22:6
Authors:
Open Access
- 17 October 2020
- journal article
- research article
- Published by Wiley in Journal of Diabetes Investigation
- Vol. 12 (6) , 950-962
Abstract
Aims/Introduction: Type 2 diabetes mellitus is closely linked to increased levels of free fatty acids (FFAs) in obese individuals, although which FFA is most associated with type 2 diabetes mellitus is unclear. This study aimed to identify the specific FFAs that best predict the occurrence of type 2 diabetes mellitus in obese individuals, and assess their potential application value.Materials and Methods: Participants were divided into three groups: a normal weight group (n = 20), an obese group (n = 10) and a type 2 diabetes mellitus group (n = 10). FFAs in serum samples were determined by ultra‐high‐pressure liquid chromatography–mass spectrometry, and orthogonal partial least squares discriminant analysis models were used to study the FFA profile among the three groups.Results: Compared with the normal weight group, 14 FFAs (C8:0/10:0/14:0/16:1/18:1/20:2/ 20:3 /20:4/ 20:5/ 22:6/7:0/9:0/11:0 and C13:0) were significantly increased in the obese group, and nine FFAs (C14:0, C18:1, C20:1, C 18:2, C20:2, C20:3, C18:3, C20:5 and C22:6) were significantly increased in the type 2 diabetes mellitus group. Subsequently, the Venn diagram results showed that six FFAs (C14:0, C18:1, C20:2, C20:3, C20:5 and C22:6) were significantly increased in both the obese and type 2 diabetes mellitus groups. Among these six, C22:6 was finally identified as an independent risk factor for type 2 diabetes mellitus, and had a great potential to predict the susceptibility to type 2 diabetes mellitus (area under the curve 0.803).Conclusions: C22:6 can be an independent risk factor for type 2 diabetes mellitus, and it has a great potential to predict the susceptibility to type 2 diabetes mellitus.Keywords
This publication has 39 references indexed in Scilit:
- Dyslipidemia in Obesity: Mechanisms and Potential TargetsNutrients, 2013
- Fat Depots, Free Fatty Acids, and DyslipidemiaNutrients, 2013
- Obesity, insulin resistance and free fatty acidsCurrent Opinion in Endocrinology, Diabetes and Obesity, 2011
- Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetesThe American Journal of Clinical Nutrition, 2011
- Free fatty acid metabolic profile and biomarkers of isolated post-challenge diabetes and type 2 diabetes mellitus based on GC–MS and multivariate statistical analysisJournal of Chromatography B, 2010
- Lipid-lowering agents and new onset diabetes mellitusExpert Opinion on Pharmacotherapy, 2010
- Metabonomic Variations in the Drug-Treated Type 2 Diabetes Mellitus Patients and Healthy VolunteersJournal of Proteome Research, 2009
- Obesity and Free Fatty AcidsEndocrinology and Metabolism Clinics of North America, 2008
- The importance of free fatty acids in the development of Type 2 diabetesDiabetic Medicine, 2007
- In vivo regulation of plasma free fatty acids in insulin resistanceMetabolism, 2004